Skip to main content
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.63
-0.14 (-1.80%)
At close: Dec 5, 2025, 4:00 PM EST
7.63
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST

Lifecore Biomedical Revenue

In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $31.11M in the quarter ending September 30, 2025, with 25.92% growth.

Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
2.06
Revenue / Employee
$317,406
Employees
406
Market Cap
285.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020 Pro Pro Pro
May 26, 2019 Pro Pro Pro
May 27, 2018 Pro Pro Pro
May 28, 2017 Pro Pro Pro
May 29, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

LFCR News

More News